How to manage refractory GERD

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 12, 2007, Pages 658-664

  Richter, Joel E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ASCORBIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2C; DAPSONE; DOXYCYCLINE; ESOMEPRAZOLE; FERROUS SULFATE; FLUTICASONE PROPIONATE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; LANSOPRAZOLE; MONTELUKAST; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; POTASSIUM CHLORIDE; PREDNISONE; PROTON PUMP INHIBITOR; QUINIDINE; RANITIDINE; STEROID; SUCRALFATE; TACROLIMUS; TETRACYCLINE; UNINDEXED DRUG;

AUTOIMMUNE SKIN DISEASE; BEDTIME DOSAGE; BILE REFLUX; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG METABOLISM; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL PH MONITORING; ESOPHAGITIS; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; ESOPHAGUS STRICTURE; EVENING DOSAGE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GENETIC VARIABILITY; GENOTYPE; HEARTBURN; HUMAN; HYPERALGESIA; MORNING DOSAGE; PATIENT COMPLIANCE; PEPTIC ULCER; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; STOMACH PARESIS; ZOLLINGER ELLISON SYNDROME;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENDOSCOPY, GASTROINTESTINAL; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; TREATMENT OUTCOME;

EID: 36649011371     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0979     Document Type: Review

References (40)

1. Bardham KD (1995) The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 9: 15-25
2. Barrison AF et al. (2001) Patterns of proton pump inhibitors in clinical practice. Am J Med 111: 469-473
3. Fass R et al. (2006) Treatment of patients with persistent heartburn symptoms: A double-blind randomized trial. Clin Gastroenterol Hepatol 4: 50-60
4. Martinez SD et al. (2003) Non-erosive reflux disease (NERD), acid reflux and symptom patterns. Aliment Pharmacol Ther 17 537-545
5. Charbel S et al. (2005) The role of esophageal pH monitoring in symptomatic patients an PPl therapy. Am J Gastroenterol 100: 283-289
6. Pandolfino JE et al. (2003) Ambulatory esophageal pH monitoring using a wireless technique. Am J Gastroenterol 98: 545-550
7. Kikendall JW (2004) Pill-induced esophageal injury. In The Esophagus edn 4, 572-584 (Eds Castell DO and Richter JE) Philadelphia: Lippincott Williams and Wilkins
8. Abid S et al. (2005) Pill-induced esophageal injury: Endoscopic features and clinical outcomes. Endoscopy 37: 470-474
9. Wise JL and Murray JA (2002) Esophageal manifestations of dermatologic disease. Curr Gastroenterol Rep 4: 205-212
10. Keate RF et al. (2003) Lichen planus: Report of three patients treated with oral tacrolimus or intraesophageal corticosteroid injection or both. Dis Esophagus 16: 47-53
11. Miller LS et al. (1990) Reflux esophagitis in patients with the Zollinger-Ellison syndrome. Gastroenterology 98: 341-346
12. Hirschowitz BI et al. (2004) Risk factors for esophagitis in extreme acid hypersecretion with and without Zollinger-Ellison syndrome. Clin Gastroenterol Hepatol 2: 220-229
13. Furuta T et al. (2002) Effect of the cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin Pharmacol Ther 72: 453-460
14. Schwab M et al. (2005) Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: Evidence from clinical and pharmacokinetic data. Clin Pharmacol Ther 78: 627-634
15. Fox VL et al. (2002) Eosinophilic esophagitis: It's not just kids stuff. Gastrointest Endosc 56: 260-270
16. Potter JW et al. (2005) Eosinophilic esophagitis in adults: An emerging problem with unique esophageal features. Gastrointest Endosc 59: 355-361
17. Desai TK et al. (2005) Association of eosinophilic inflammation with esophageal food impaction. Gastrointest Endosc 61: 795-801
18. Gonsalves N et al. (2006) Histopathologic variability and endoscopic correlation in adults with eosinophilic esophagitis. Gastrointest Endosc 64: 113-119
19. Mishra A et al. (2001) An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 107: 83-90
20. Morrow JB et al. (2001) The ringed esophagus: Histological features of GERD. Am J Gastroenterol 96: 984-989
21. Ngo P et al. (2006) Eosinophils in the esophagus-peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 101: 1666-1670
22. Straumann A et al. (2003) Natural history of primary eosinophilic esophagitis: A follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125: 1660-1669
23. Teitelbaum J et al. (2002) Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 122: 1216-1225
24. Konikoff MR et al. (2006) A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131: 1381-1391
25. Peghini PL et al. (1998) Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: A controlled study in normal subjects. Gastroenterology 115: 1335-1339
26. 2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 122: 625-632
27. 2-receptor antagonists. Dig Dis Sci 35: 976-983
28. Sifrim D et al. (2001) Acid, non-acid, and gas reflux in patients with gastro-esophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 120: 1588-1598
29. Vaezi MF et al. (1994) Validation studies of Bilitec 2000: An ambulatory duodenogastric reflux monitoring system. Am J Physiol 267: G1050-G1075
30. Koek GH et al. (2001) The role of acid and duodenal gastroesophageal reflux in symptomatic GERD. Am J Gastroenterol 96: 2033-2040
31. Marshall RE et al. (1997) The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 40: 182-187
32. Zerbib F et al. (2006) Esophageal pH-impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy. Am J Gastroanterol 101: 1956-1963
33. Mainie I et al. (2006) Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicenter study using ambulatory impedance-pH monitoring. Gut 55: 1398-1402
34. B agonist baclofen in patients with symptoms and DGE reflux refractory to proton pump inhibitors. Gut 52: 1397-1402
35. Fletcher J et al. (2004) Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: Evidence of stat segment reflux. Gut 53 168-173
36. Galmiche JP et al. (2006) Functional esophageal disorder. Gastroenterology 130: 1459-1465
37. Smout AJPM (1997) Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther 11 (Suppl 2): 81-85
38. Fass R and Tougas G (2002) Functional heartburn: The stimulus, the pain and the brain. Gut 51: 885-892
39. Mayer EA and Gebhart GF (1994) Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107: 271-293
40. Dhir R and Richter JE (2004) Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol 38: 237-242